SCHEMBL2556575

SCHEMBL2556575

Cc1ccc(-c2ncccn2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 2/20 0.58
ADRB2 P07550 1/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
TP53 P04637 1/20 0.46
PKM P14618 1/20 0.46
NISCH Q9Y2I1 1/20 0.45
CYP2A6 P11509 1/20 0.44
NPC1 O15118 5/20 0.44
RAB9A P51151 4/20 0.44
ALDH1A1 P00352 2/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
COMT P21964 1/20 0.43
KDM4E B2RXH2 1/20 0.43
GAA P10253 1/20 0.43
NR1H2 P55055 1/20 0.42
NR1H3 Q13133 1/20 0.42
ACHE P22303 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25954435 0.97 CLK4 (0.56) CLK4ADRB2MEN1KMT2ATP53
SCHEMBL21018825 0.87 CLK4 (0.47) CLK4ADRB2MEN1KMT2ATP53
SCHEMBL27256810 0.86 ALDH1A1 (0.47) CLK4ADRB2MEN1KMT2ATP53
SCHEMBL17051406 0.86 CLK4 (0.45) CLK4ADRB2MEN1KMT2ATP53
SCHEMBL12628231 0.86 MEN1 (0.50) CLK4ADRB2MEN1KMT2ATP53
SCHEMBL6685962 0.86 CLK4 (0.64) CLK4ADRB2MEN1KMT2ATP53
SCHEMBL17055369 0.85 CLK4 (0.54) CLK4ADRB2MEN1KMT2ATP53
SCHEMBL18325246 0.84 CLK4 (0.49) CLK4ADRB2MEN1KMT2ATP53
SCHEMBL2300946 0.84 MEN1 (0.45) CLK4ADRB2MEN1KMT2ATP53
SCHEMBL16625771 0.83 CLK4 (0.61) CLK4ADRB2MEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100534991-C Heterocyclic inhibitors of ERK 2 and uses thereof VERTEX PHARMA (US) 2009-09-02 CN claimed
CN-1494541-A heterocyclic inhibitors of ERK2 and uses thereof ��̩��˹ҩ��ɷ����޹�˾ 2004-05-05 CN claimed
US-20240244946-A1 ORGANIC LIGHT EMITTING DIODE COMPRISING ORGANOMETALLIC COMPOUND AND PLURALITY OF HOST MATERIALS LG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
US-20240244947-A1 ORGANIC LIGHT EMITTING DIODE COMPRISING ORGANOMETALLIC COMPOUND AND PLURALITY OF HOST MATERIALS LG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
US-20240244947-A1 ORGANIC LIGHT EMITTING DIODE COMPRISING ORGANOMETALLIC COMPOUND AND PLURALITY OF HOST MATERIALS LG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
US-20240244946-A1 ORGANIC LIGHT EMITTING DIODE COMPRISING ORGANOMETALLIC COMPOUND AND PLURALITY OF HOST MATERIALS LG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
CN-110088115-B Organometallic complex, light-emitting element, light-emitting device, electronic device, and lighting device 株式会社半导体能源研究所 2024-05-14 CN disclosed
WO-2024086361-A1 MOLECULAR GLUE DEGRADER COMPOUNDS AND USES THEREOF NOVARTIS AG (CH) 2024-04-25 WO disclosed
EP-3875151-B1 ALPHA-METHYL-SUBSTITUTED DIAZABICYCLO [4.3.1] DECANE DERIVATES FOR TREATMENT OF PSYCHIATRIC DISORDERS UNIV DARMSTADT TECH (DE) 2023-09-20 EP disclosed
US-20230217811-A1 COMPOUNDS AND ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-07-06 US disclosed
US-20230217811-A1 COMPOUNDS AND ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-07-06 US disclosed
US-4859670-A 2-Azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof, agents containing same, and the use thereof HOECHST AKTIENGESELLSCHAFT (DE) 1989-08-22 US disclosed
EP-0237962-A2 2-Azolylmethyl-2-aryl-1,3-dioxolanes and their preparation, compositions containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1987-09-23 EP disclosed
EP-0031796-B1 4-HETEROCYCLYL-4'-VINYL-STILBENES CIBA-GEIGY AG (CH) 1985-01-23 EP disclosed
EP-0020298-B1 BENZOXAZOLYL STILBENES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS OPTICAL BRIGHTENERS FOR ORGANIC MATERIALS CIBA-GEIGY AG (CH) 1983-06-22 EP disclosed
US-4366189-A WHITENERS CIBA-GEIGY CORPORATION (US) 1982-12-28 US disclosed
US-4297234-A OPTICAL BRIGHTENERS CIBA-GEIGY CORPORATION (US) 1981-10-27 US disclosed
EP-0031796-A2 4-Heterocyclyl-4'-vinyl-stilbenes CIBA-GEIGY AG (CH) 1981-07-08 EP disclosed
EP-0020298-A1 Benzoxazolyl stilbenes, process for their preparation and their use as optical brighteners for organic materials CIBA-GEIGY AG (CH) 1980-12-10 EP disclosed
US-3940395-A CNS DEPRESSANT AMERICAN HOME PRODUCTS CORPORATION (US) 1976-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240244946-A1 ORGANIC LIGHT EMITTING DIODE COMPRISING ORGANOMETALLIC COMPOUND AND PLURALITY OF HOST MATERIALS GPX1, PER2, SOD1 CLK4 556/4885ADRB2 4162/4885MEN1 1557/4885
US-20230217811-A1 COMPOUNDS AND ORGANIC ELECTRONIC DEVICES ETV6, CYP2C19, AFF2 CLK4 3415/4885ADRB2 2062/4885MEN1 292/4885
US-20240244947-A1 ORGANIC LIGHT EMITTING DIODE COMPRISING ORGANOMETALLIC COMPOUND AND PLURALITY OF HOST MATERIALS PER2, GPX1, SOD1 CLK4 567/4885ADRB2 4237/4885MEN1 1517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.